{"id":36712,"date":"2015-09-09T08:29:15","date_gmt":"2015-09-09T12:29:15","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=36712"},"modified":"2015-09-09T08:29:15","modified_gmt":"2015-09-09T12:29:15","slug":"pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712","title":{"rendered":"Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5%"},"content":{"rendered":"

Pharmacyte Biotech Inc (OTCMKTS:PMCB)<\/strong> updated<\/a> on the process of the compliance process completion of the Austrianova\u2019s current Good Manufacturing Practices-compliant facility in Thailand. The encapsulation process of genetically modified human cells in the unique Cell-in-a-Box\u00ae capsules will be carried out in this facility. This are the same capsules that the company intends to use in its clinical trials targeting diseases like cancer and diabetes.<\/p>\n

In the last trading session, the stock price of Pharmacyte declined over 5% to close the trading session at $.0910. The decline came at a share volume of 2.27 million compared to average monthly share volume of 1.44 million.<\/p>\n

Uluru Inc (OTCMKTS:ULUR)<\/strong> reported<\/a> that during last quarter, the company released encouraging interim data for its pharmaco-economic assessment being conducted in Europe. The biggest news came from Russia as it received marketing approval for the sale of Altrazeal\u00ae by the governing bodies. Also, the company started with the initial shipment of Altrazeal for Egypt and Saudi Arabia.<\/p>\n

ULURU comes in the list of specialty pharmaceutical firms focused on the development of oral care and wound management products. In last trading session, the stock price of Uluru declined over 5% to close the trading session at $0.320. The decline came at a share volume of 20,527 compared to average share volume of 15,665.<\/p>\n

Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) <\/strong>reported<\/a> that launch of its new Alevicyn SG Antipruritic Spray Gel for pain and Itch relief in Atopic Dermatitis. The spray is formulated with the Microcyn Technology and is meant to relive the pain, itching and burning experienced with several types of dermatoses, such as atopic dermatitis and radiation dermatitis.<\/p>\n

In last trading session, the stock price of Oculus declined more than 5% to close the trading session at $$1.15. The decline came at a share volume of 129,876 compared to average monthly share volume of 530,758.<\/p>\n","protected":false},"excerpt":{"rendered":"

Pharmacyte Biotech Inc (OTCMKTS:PMCB) updated on the process of the compliance process completion of the Austrianova\u2019s current Good Manufacturing Practices-compliant facility in Thailand. The encapsulation […]<\/p>\n","protected":false},"author":12,"featured_media":26999,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[2545,11689,2544,11643,11679,11642,11641,11678,11677],"stock_ticker":[],"class_list":["post-36712","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-nasdaqocls","tag-oculus-innovative-sciences-inc","tag-oculus-innovative-sciences-inc-nasdaqocls","tag-otcmktspmcb","tag-otcmktsulur","tag-pharmacyte-biotech-inc","tag-pharmacyte-biotech-inc-otcmktspmcb","tag-uluru-inc","tag-uluru-inc-otcmktsulur","entry"],"acf":[],"yoast_head":"\nPharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5% - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5% - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) updated on the process of the compliance process completion of the Austrianova\u2019s current Good Manufacturing Practices-compliant facility in Thailand. The encapsulation […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-09-09T12:29:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"216\" \/>\n\t<meta property=\"og:image:height\" content=\"234\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5%\",\"datePublished\":\"2015-09-09T12:29:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712\"},\"wordCount\":317,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg\",\"keywords\":[\"NASDAQ:OCLS\",\"Oculus Innovative Sciences Inc.\",\"Oculus Innovative Sciences Inc. (NASDAQ:OCLS)\",\"OTCMKTS:PMCB\",\"OTCMKTS:ULUR\",\"Pharmacyte Biotech Inc\",\"Pharmacyte Biotech Inc (OTCMKTS:PMCB)\",\"Uluru Inc\",\"Uluru Inc (OTCMKTS:ULUR)\"],\"articleSection\":[\"Business\",\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712\",\"name\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5% - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg\",\"datePublished\":\"2015-09-09T12:29:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg\",\"width\":216,\"height\":234},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5% - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712","og_locale":"en_US","og_type":"article","og_title":"Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5% - Wall Street PR","og_description":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) updated on the process of the compliance process completion of the Austrianova\u2019s current Good Manufacturing Practices-compliant facility in Thailand. The encapsulation […]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-09-09T12:29:15+00:00","og_image":[{"width":216,"height":234,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5%","datePublished":"2015-09-09T12:29:15+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712"},"wordCount":317,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg","keywords":["NASDAQ:OCLS","Oculus Innovative Sciences Inc.","Oculus Innovative Sciences Inc. (NASDAQ:OCLS)","OTCMKTS:PMCB","OTCMKTS:ULUR","Pharmacyte Biotech Inc","Pharmacyte Biotech Inc (OTCMKTS:PMCB)","Uluru Inc","Uluru Inc (OTCMKTS:ULUR)"],"articleSection":["Business","Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712","name":"Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5% - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg","datePublished":"2015-09-09T12:29:15+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/07\/CTI-BioPharma-Corp1.jpg","width":216,"height":234},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-uluru-inc-otcmktsulur-and-oculus-innovative-sciences-inc-nasdaqocls-declines-over-5-36712#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5%"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=36712"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36712\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/26999"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=36712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=36712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=36712"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=36712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}